RxDoctor Payments Data

Frank Wood, MD

Family Medicine · Mc Caysville, GANPI 1730141672

Payments from drug & device makers

$602in general payments, 2019–2025

Across 20 payments — averaging $30.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$177
  • AstraZeneca$148
  • Novo Nordisk$125
  • Sanofi-aventis U.S. LLC$54
  • Pfizer$40
  • Johnson & Johnson$21
  • plus $36 from 2 others

What the payments were for

  • Food & beverage$602100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$602 in reported general payments places this provider in the 50th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$175,396
Medicare patients
146
Services billed
8,377

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide81$92,004
EliquisApixaban90$68,451
JanuviaSitagliptin Phosphate67$48,112
MounjaroTirzepatide38$40,864
Trelegy ElliptaFluticasone/Umeclidin/Vilanter55$38,421
LinzessLinaclotide62$37,019
FarxigaDapagliflozin Propanediol47$31,734
JardianceEmpagliflozin33$20,987
Combivent RespimatIpratropium/Albuterol Sulfate22$14,510
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen840$13,640
EntrestoSacubitril/Valsartan22$13,308
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog17$13,052
Tresiba Flextouch U-100Insulin Degludec13$12,735
BrilintaTicagrelor24$10,297
Janumet XrSitagliptin Phos/Metformin Hcl24$9,913

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$125$92,00481 claims
PfizerEliquis, Premarin$40$71,615107 claims
GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta$18$51,62891 claims
AstraZenecaFarxiga, Brilinta, Symbicort$148$45,50287 claims
AbbVieLinzess$177$37,01962 claims
Sanofi-aventis U.S. LLCLantus$54$4,86323 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Mc Caysville

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →